The University Medical Center Groningen, formerly Groningen University Hospital, is the main hospital in Groningen, Netherlands. The medical centre is affiliated with the University of Groningen and offers supraregional tertiary care to the northern part of the Netherlands.

During the past decade, Universitair Medisch Centrum Groningen; Department of Rheumatology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitair Medisch Centrum Groningen; Department of Rheumatology" are "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Universitair Medisch Centrum Groningen; Department of Rheumatology" in a lesser frequency.

Most popular intervention types in "Universitair Medisch Centrum Groningen; Department of Rheumatology" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Methotrexate" (1 trials), "Non-Biologic DMARDs" (1 trials) and "Tocilizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitair Medisch Centrum Groningen; Department of Rheumatology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitair Medisch Centrum Groningen; Department of Rheumatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Universitair Medisch Centrum Groningen; Department of Rheumatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitair Medisch Centrum Groningen; Department of Rheumatology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".